This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: University System of Maryland. Active years: 2005-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2012
Title: Innovations of Timothy R. Fouts
Introduction
Timothy R. Fouts is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric molecules that have potential applications in inhibiting viral infections.
Latest Patents
Fouts holds 4 patents, with his latest inventions focusing on virus coat protein/receptor chimeras and methods of use. These inventions relate to chimeric molecules that comprise a virus coat sequence and a receptor sequence capable of interacting to form a complex that binds a co-receptor. Such chimeric molecules exhibit functional properties characteristic of a receptor-coat protein complex. They are useful as agents that inhibit virus infection of cells due to the occupancy of a co-receptor present on the cell. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV, and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include CCR5, CXCR4, CD4 D1D2, and CD4M9 sequences.
Career Highlights
Fouts is affiliated with the University System of Maryland, where he continues to advance his research and innovations in the field of virology and molecular biology. His work has the potential to contribute significantly to therapeutic strategies against viral infections.
Collaborations
Some of his notable coworkers include Robert G. Tuskan and Anthony Louis Devico, who have collaborated with him on various research projects.
Conclusion
Timothy R. Fouts is a distinguished inventor whose work on chimeric molecules is paving the way for new approaches to combat viral infections. His contributions to biotechnology are invaluable and continue to inspire further research in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
